Enhancement of 5-aminolaevulinic acid-induced photodynamic therapy in normal rat colon using hydroxypyridinone iron-chelating agents
Authors:
- Bw McllroyBMBw Mcllroy
- Mj Postle-HaconMPMj Postle-Hacon
- Jb PorterJPJb Porter
- AJ MacRobertAMAJ MacRobert
- Sg BownSBSg Bown
Open Access
- 1 November 1998
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 78 (10) , 1278-1282
Abstract
Currently, the clinical use of 5-aminolaevulinic acid (ALA)-induced protoporphyrin IX (PPIX) for photodynamic therapy (PDT) is limited by the maximum tolerated oral ALA dose (60 mg kg(-1)). This study investigates whether hydroxypyridinone iron-chelating agents can be used to enhance the tissue levels of PPIX, without increasing the administered dose of ALA. Quantitative charge-coupled device (CCD) fluorescence microscopy was employed to study PPIX fluorescence pharmacokinetics in the colon of normal Wistar rats. The iron chelator, CP94, when administered with ALA was found to produce double the PPIX fluorescence in the colonic mucosa, compared with the same dose of ALA given alone and to be more effective than the other iron chelator studied, CP20. Microspectrofluorimetric studies demonstrated that PPIX was the predominant porphyrin species present. PDT studies conducted on the colonic mucosa showed that the simultaneous administration of 100 mg kg(-1) CP94 i.v. and 50 mg kg(-1) ALA i.v. produced an area of necrosis three times larger than similar parameters without the iron-chelating agent with the same light dose. It is possible, therefore, to increase the amount of necrosis produced by ALA-induced PDT substantially, without increasing the administered dose of ALA, through the simultaneous administration of the iron-chelating agent, CP94.Keywords
This publication has 7 references indexed in Scilit:
- The Relationship of Intracellular Iron Chelation to the Inhibition and Regeneration of Human Ribonucleotide ReductaseJournal of Biological Chemistry, 1996
- The Environment of the Lipoxygenase Iron Binding Site Explored with Novel Hydroxypyridinone Iron ChelatorsJournal of Biological Chemistry, 1996
- Subcellular distribution of desferrioxamine and hydroxypyridin‐4‐one chelators in K562 cells affects chelation of intracellular iron poolsBritish Journal of Haematology, 1993
- Contrasting interspecies efficacy and toxicology of 1, 2 ‐diethy 1–3 ‐hydroxypyridin‐4‐one, CP9 4, relates to differing metabolism of the iron chelating siteBritish Journal of Haematology, 1993
- Fluorescence distribution and photodynamic effect of ALA-induced PP IX in the DMH rat colonic tumour modelBritish Journal of Cancer, 1992
- Human erythroid 5‐aminolevulinate synthase: promoter analysis and identification of an iron‐responsive element in the mRNA.The EMBO Journal, 1991
- Iron mobilization from myocardial cells by 3-hydroxypyridin-4-one chelators: studies in rat heart cells in culture.1991